How Women in Business Development can overcome industry challenges

It’s no secret that women across a spectrum of industries often face challenges when trying to get ahead and make their mark in the business marketplace. The business development field in particular is typically heavily dominated by men. So how can companies begin to strike a better balance that enables women to take their place at the table?

To answer this question, 20 leaders from Forbes Business Development Council each offer one tip to help women in the biz dev space overcome the challenges they face in the industry—whether it’s gaining a client’s trust, being respected by colleagues or closing on a deal with a potential new business partner.

Find A Mentor Who Understands Your Path

It’s all about self-confidence and professionalism. If both elements are present, trust and respect will follow. For some, these qualities come naturally; others can find ways to grow their confidence. One of the best methods I’ve seen in recent years is through mentorship programs, where you are inspired and motivated by a mentor who may have faced similar struggles in their work path. – Egle Pavyde, hVIVO PLC

hVIVO plc (formerly Open Orphan plc), led by Cathal Friel, is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and antivirals using human challenge clinical trials, providing end-to-end early clinical development services for its broad and long-standing client base of biopharma companies.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    X
    LinkedIn
    hVIVO plc

    More articles like this

    hVIVO plc

    hVIVO 2024 Year in Review

    Discover how hVIVO Group’s innovative approach to human challenge trials and infectious disease expertise has shaped the future of pharmaceutical research in 2024.

    hVIVO plc

    Blood biomarkers for viral infection diagnosis and management

    Host response biomarkers to viral infections have significant potential in clinical applications, such as guiding diagnostic decisions, reducing unnecessary antibiotic use, and triggering infection control protocols or antiviral treatments. Research on these biomarkers has largely focused

    hVIVO plc

    Impact of patient perception on vaccine and drug efficacy

    Human viral challenge studies have become essential in evaluating the effectiveness of vaccines, treatments, and prophylactics, providing quicker results compared to larger Phase 2a/b field trials. hVIVO has developed various challenge agents for human use, including

    hVIVO plc

    Versatile MDCK cells in research and biotechnology

    MDCK (Madin-Darby Canine Kidney) cells are an essential tool in biological and medical research, especially in virology, cell biology, and studies involving membrane transport. Originally derived in 1958 from the kidney of a healthy adult female

    hVIVO plc

    Exploring the human viral challenge model for influenza research

    This study evaluates the human viral challenge model using the A/Perth/16/2009 H3N2 influenza virus, involving 216 volunteers across five clinical studies. Administered intranasally under controlled conditions, the research aimed to improve the understanding of influenza infection

    hVIVO plc

    Advancing influenza research with new challenge agents

    Controlled Human Infection Studies (CHIS) have proven to be essential in exploring human responses to respiratory infections and testing the effectiveness of vaccines and treatments. These studies hinge on selecting an appropriate challenge virus, making a